JW Pharmaceutical Corporation の製品パイプライン分析2016

Global Markets Directが発行した調査報告書(DATA70209163)
◆英語タイトル:JW Pharmaceutical Corporation - Product Pipeline Review - 2016
◆商品コード:DATA70209163
◆発行会社(リサーチ会社):Global Markets Direct
◆発行日:2016年9月30日
◆ページ数:39
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
Site LicenseUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprisewide (Global Site License)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Markets Direct社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Global Markets Direct社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

JW Pharmaceutical Corporation – Product Pipeline Review – 2016
Summary

Global Markets Direct’s, ‘JW Pharmaceutical Corporation – Product Pipeline Review – 2016’, provides an overview of the JW Pharmaceutical Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by JW Pharmaceutical Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of JW Pharmaceutical Corporation
- The report provides overview of JW Pharmaceutical Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses JW Pharmaceutical Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features JW Pharmaceutical Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate JW Pharmaceutical Corporation’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for JW Pharmaceutical Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding JW Pharmaceutical Corporation’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
JW Pharmaceutical Corporation Snapshot 5
JW Pharmaceutical Corporation Overview 5
Key Facts 5
JW Pharmaceutical Corporation – Research and Development Overview 6
Key Therapeutic Areas 6
JW Pharmaceutical Corporation – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
Pipeline Products – Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
JW Pharmaceutical Corporation – Pipeline Products Glance 14
JW Pharmaceutical Corporation – Late Stage Pipeline Products 14
Phase III Products/Combination Treatment Modalities 14
JW Pharmaceutical Corporation – Clinical Stage Pipeline Products 15
Phase I Products/Combination Treatment Modalities 15
JW Pharmaceutical Corporation – Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
JW Pharmaceutical Corporation – Drug Profiles 18
(pitavastatin + valsartan) – Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
CW-108F – Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
CWF-0701 – Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
CWF-0771 – Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
CWF-07pre03 – Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
CWF-0808 – Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
CWF-09pre02 – Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
CWP-232228 – Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
CWP-291 – Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
docetaxel – Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
JWF-1103 – Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
JWF-1201 – Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
JW Pharmaceutical Corporation – Pipeline Analysis 30
JW Pharmaceutical Corporation – Pipeline Products by Target 30
JW Pharmaceutical Corporation – Pipeline Products by Route of Administration 32
JW Pharmaceutical Corporation – Pipeline Products by Molecule Type 33
JW Pharmaceutical Corporation – Pipeline Products by Mechanism of Action 34
JW Pharmaceutical Corporation – Dormant Projects 36
JW Pharmaceutical Corporation – Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 38
Disclaimer 3

List of Tables
JW Pharmaceutical Corporation, Key Facts 5
JW Pharmaceutical Corporation - Pipeline by Indication, 2016 8
JW Pharmaceutical Corporation - Pipeline by Stage of Development, 2016 9
JW Pharmaceutical Corporation - Monotherapy Products in Pipeline, 2016 10
JW Pharmaceutical Corporation - Combination Treatment Modalities in Pipeline, 2016 11
JW Pharmaceutical Corporation - Partnered Products in Pipeline, 2016 12
JW Pharmaceutical Corporation - Partnered Products/ Combination Treatment Modalities, 2016 13
JW Pharmaceutical Corporation - Phase III, 2016 14
JW Pharmaceutical Corporation - Phase I, 2016 15
JW Pharmaceutical Corporation - Preclinical, 2016 16
JW Pharmaceutical Corporation - Discovery, 2016 17
JW Pharmaceutical Corporation - Pipeline by Target, 2016 31
JW Pharmaceutical Corporation - Pipeline by Route of Administration, 2016 32
JW Pharmaceutical Corporation - Pipeline by Molecule Type, 2016 33
JW Pharmaceutical Corporation - Pipeline Products by Mechanism of Action, 2016 35
JW Pharmaceutical Corporation - Dormant Developmental Projects,2016 36

List of Figures
JW Pharmaceutical Corporation - Pipeline by Top 10 Indication, 2016 7
JW Pharmaceutical Corporation - Pipeline by Stage of Development, 2016 9
JW Pharmaceutical Corporation - Monotherapy Products in Pipeline, 2016 10
JW Pharmaceutical Corporation - Partnered Products in Pipeline, 2016 12
JW Pharmaceutical Corporation - Pipeline by Top 10 Target, 2016 30
JW Pharmaceutical Corporation - Pipeline by Route of Administration, 2016 32
JW Pharmaceutical Corporation - Pipeline by Molecule Type, 2016 33
JW Pharmaceutical Corporation - Pipeline Products by Top 10 Mechanism of Action, 2016 34

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ JW Pharmaceutical Corporation の製品パイプライン分析2016(JW Pharmaceutical Corporation - Product Pipeline Review - 2016)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆